We previously demonstrated that Scu is a selective inhibitor of TRPV3 and Scu alleviates DNFB and carvacrol-induced pruritus and dermatitis through specific suppression of TRPV3 (Wang et al., 2022). The gene discussed is TRPV3; the disease is dermatitis.